Cite
'Formulation For Inhibiting Formation Of 5-Ht2b Agonists And Methods Of Using Same' in Patent Application Approval Process (USPTO 20190083425)
MLA
“‘Formulation For Inhibiting Formation Of 5-Ht2b Agonists And Methods Of Using Same’ in Patent Application Approval Process (USPTO 20190083425).” Drug Week, 12 Apr. 2019, p. 393. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.581518393&authtype=sso&custid=ns315887.
APA
“Formulation For Inhibiting Formation Of 5-Ht2b Agonists And Methods Of Using Same” in Patent Application Approval Process (USPTO 20190083425). (2019, April 12). Drug Week, 393.
Chicago
Drug Week. 2019. “‘Formulation For Inhibiting Formation Of 5-Ht2b Agonists And Methods Of Using Same’ in Patent Application Approval Process (USPTO 20190083425),” April 12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.581518393&authtype=sso&custid=ns315887.